Choosing to embark on a journey that provides you with freedom from your addiction represents a significant leap forward in your recovery. As a leading addiction and mental health treatment organization, the Harmony Health Group has multiple programs that offer medication-assisted treatment programs in Florida, Massachusetts, North Carolina, New Jersey, and Tennessee. 

Harmony Addiction Recovery Group treatment facilities are often in-network with many health insurance providers and accept insurance coverage for those who engage in medication-assisted treatment. With approximately 26% of those struggling with drug abuse being uninsured, we understand that you may have concerns about the cost of treatment. We encourage you to dial (866) 461-4474 today to speak with an Admissions Counselor about payment plan options for our programs that are welcoming new clients!

What is Medication-Assisted Treatment (MAT)?

MAT (Medication-assisted treatment) is an evidence-based treatment approach for substance use disorders that combines the use of behavioral therapies with medications that can ease physical and psychological symptoms associated with addiction. These FDA-approved medications can make it easier to manage cravings, withdrawal symptoms, and other physical effects of addiction.

MAT can be an effective treatment option for individuals who are struggling with nicotine products, alcohol, benzodiazepines, and opioids including pain medication and heroin addiction. Opioid use disorder treatment can include the use of buprenorphine, methadone maintenance programs, naltrexone therapy, Vivitrol, and Suboxone treatment. Treatment for alcohol use disorder can include medications such as naltrexone, Vivitrol, acamprosate (Campral), and disulfiram (Antabuse). Anticonvulsants, antidepressants, a benzodiazepine taper, and Flumazenil may be used to treat a benzodiazepine use disorder. Depending on the details of your use, you may be eligible for MAT counseling services in an inpatient or outpatient treatment program. Your care can include the use of individual therapy, group therapy, support groups, and educational sessions that can help address the root of your addiction.

What is Medication-Assisted Inpatient Treatment?

Inpatient rehabilitation programs often provide medication-assisted treatment for individuals who are experiencing withdrawal symptoms and are in the beginning stages of their recovery. Medication-assisted detox programs are commonly used by those who are experiencing withdrawal symptoms and can utilize medication-assisted therapy options to provide relief for withdrawal symptoms that you may experience. 

Depending on the substance, or substances, that an individual is using, medication-assisted treatment could be a beneficial component of their recovery plan. Opioid addiction medications can be used to help manage cravings and decrease the risk of an overdose, should an individual relapse. Similarly, alcohol addiction medications can help manage cravings, and reduce the euphoric effects of alcohol to discourage alcohol use. Beginning your medication regimen in an inpatient setting provides your body with time to adjust to your new medication, and for you to develop an understanding of how this medication supports you in your recovery. Inpatient treatment programs can vary widely in length because they are dependent on personal characteristics, including the severity of your addiction, physical symptoms, and your experience with other mental health concerns.

What is Medication-Assisted Outpatient Treatment?

MAT in addiction treatment programs including intensive outpatient programs (IOP) and routine outpatient care allow individuals to live at home, and maintain their daily responsibilities as they engage in treatment. Outpatient MAT programs combine therapy and counseling services with a continuous relationship with a physician or other healthcare provider who can provide medical monitoring and adjust medication regimens as needed. 

Individuals who utilize MAT on an outpatient basis are often less likely to require detox support and are often actively working towards their recovery goals. Medication-assisted treatment at this stage in recovery can aid in a person’s ability to cope with and manage cravings and triggers while reducing the euphoric effects and the risk of an overdose if they were to relapse. Outpatient MAT programs can include various behavioral health interventions including group therapy, individual therapy, dual diagnosis treatment, and family therapy. 

What is Medication-Assisted Partial Hospitalization Treatment?

Partial hospitalization treatment programs (PHP) that offer medication-assisted treatment provide an intensive, and structured addiction treatment program with the benefits of an outpatient treatment program. PHPs are designed for individuals who require a higher level of care, but do not require around-the-clock support like what you would find in an inpatient rehabilitation program. Partial hospitalization programs are also known as day programs because they provide you with a full 6–8 hours of various treatment approaches before you return home for the evenings, typically 5 days a week. 

Those who utilize medication-assisted treatment options while engaging in a PHP are not likely to require support for withdrawal, rather, these individuals have their feet on the ground in their recovery and are actively taking steps to move towards their recovery goals. With comprehensive treatment options, individuals can remain in their home environment while receiving medical supervision, therapy, and support services from their medication-assisted recovery programs. 

Statistics on Medication-Assisted Treatment

Contact Harmony Health Group Today

You can contact us through the form below or by calling us at: (866) 461-4474

Name
disclaimer(Required)

We’re here to listen. Let’s talk today.

Finding Medication-Assisted Treatment Centers Near Me

You’ve reached the point in your journey where you are wondering if using medication-assisted treatment medications could support you in your recovery, but you are unsure where you can get the help you are looking for close by. Dial (866) 461-4474 to learn about the Harmony Drug and Alcohol Addiction Recovery Group’s options for medication-assisted treatment for substance use disorders.

MAT Facilities in Massachusetts

MAT Facilities in New Jersey

MAT Facilities in Tennessee

MAT Facilities in Florida

MAT Facilities in North Carolina

Harmony offers a multitude of locations up and down the East Coast for behavioral health services. Call us to learn about our facilities and treatment options.

Medication-Assisted Treatment for Opioid Use Disorder

Medication-assisted treatment for opioid use disorder combines the use of FDA-approved medications with behavioral therapies including counseling and therapy. Widely regarded as the golden standard for opioid addiction treatment, MAT can include methadone, buprenorphine, and naltrexone. These medications vary significantly, impacting their suitability for individuals based on their unique needs.

Methadone for Opioid Addiction Treatment

Buprenorphine for Opioid Addiction Treatment

Naltrexone for Opioid Addiction Treatment

Medication-Assisted Treatment for Alcohol Use Disorder

Medication-assisted treatment for alcohol use disorder can help individuals reduce their alcohol intake, reduce cravings, and prevent a relapse. MAT for alcohol use disorder is most impactful with it is combined with behavioral therapy options, including both inpatient rehabilitation programs and outpatient treatment options, such as partial hospitalization programming and intensive outpatient programs.  

Disulfiram for Alcohol Addiction Treatments

Disulfiram, also known as Antabuse, is a safe and effective MAT option on a short-term basis for individuals who are struggling with alcohol use disorder. The purpose of this medication is to produce adverse effects when someone drinks, increasing their motivation to abstain from alcohol use. 

Individuals who drink while taking disulfiram experience palpations, facial flushing, nausea, vertigo, hypotension, and tachycardia. The extent to which a person experiences these symptoms is dependent on the dose of the medication they take, as well as the amount of alcohol that they consume. Disulfiram is only available in a tablet at this time. Common side effects associated with this medication include headaches, sleepiness, tiredness, and a metallic taste in the mouth.   

Acamprosate for Alcohol Addiction Treatment

60-Day Inpatient Rehab Program

Naltrexone for Alcohol Addiction Treatment

6-Month, 12-Month and 24-Month Inpatient Rehab

Medication-Assisted Treatment for Benzodiazepine Use Disorder

The use of MAT for benzodiazepine use disorder is not as common as MAT for the use of opioid and alcohol use disorders because there are limited medications available to be used. Treatment for a benzodiazepine use disorder often includes the use of anticonvulsants, antidepressants, a benzodiazepine taper, and medications that can provide relief from withdrawal symptoms.  

Flumazenil for Benzo Addiction Treatment

Flumazenil is a benzodiazepine antagonist which has FDA approval as a reversal medication for a benzodiazepine overdose, and to reverse the sedative effects that can occur with abuse and misuse of prescription benzodiazepines. This medication is used on a limited basis and is typically administered only in emergencies. 

Flumazenil can be used to reverse a coma that occurred as a result of an overdose, and can be effective in reversing some comas that were initiated by polysubstance abuse. When taken, 80% of the body’s response occurs within three minutes, and the duration of effectiveness can range from 19 to 50 minutes depending on the dose given, and the amount of benzodiazepines in a person’s system. Serious adverse side effects that are known to occur with the use of Flumazenil include sedation, neurological effects, seizure, and arrhythmias.

Check Your Insurance Coverage

Name of Client(Required)
Name
disclaimer(Required)

Does Insurance Cover Medication-Assisted Treatment?

The simple answer is yes, insurance should provide you with partial or full coverage for medication-assisted treatment. Health insurance plans are required to provide coverage for behavioral health treatment, mental health inpatient treatment services, and substance use disorder treatment under the Affordable Care Act of 2010. Your healthcare plan can vary greatly in coverage provided and your out-of-pocket costs.

Which Insurance Providers Cover MAT Programs?

Many health insurance companies in the United States provide coverage for medication-assisted programs for addiction. Your coverage can vary based on your individual plan, state regulations, and personal characteristics. Verifying your insurance with the Harmony Health Group can help you understand the bounds of your coverage. Companies that often provide MAT coverage at the Harmony Health Group include: 

How Much Does Medication-Assisted Treatment Cost Without Insurance?

The costs of MAT in addiction treatment can vary based on a number of factors including the medication being used, adjunct behavioral approaches used, the level of care being provided, and the duration of your care. Individuals who are receiving dual diagnosis MAT may also have a higher cost of care if they are using psychotropic medications as well. 

The National Institute on Drug Abuse estimated that the price for opioid treatment programs is as follows:

  • Methadone treatment: Daily visits to a MAT clinic with integrated psychosocial and medical support averaged $126 per week and $6,552 annually
  • Buprenorphine treatment: Treatment including outpatient treatment programs twice per week typically costs $115 per week and $5,980 annually
  • Naltrexone treatment: Treatment including outpatient treatment and drug administration costs around $1,176.50 per month and $14,112 annually

Long-Term Medication-Assisted Treatment Programs 

Medication-assisted recovery programs can vary significantly among those who utilize this treatment resource. The length of treatment is dependent on individual characteristics, including the severity of addiction and overall treatment goals. Healthcare providers will provide you with an understanding of your treatment options, and work with you to determine the best course of action for you and your recovery.

30-Day (One Month) MAT Programs

60-Day (Two Month) MAT Programs

90-Day (Three Month) MAT Programs

180-Day (Six Month) MAT Programs

Short-Term Medication-Assisted Treatment Programs 

Short-term MAT programs can be effective for individuals who are experiencing a crisis, and those in a detoxification program. Typically, longer treatment durations are associated with better treatment outcomes. Short-term MAT programs often encourage continued addiction treatment to aid in the development of skills needed for a healthy and lasting recovery. 

Weekend MAT Programs

3-Day, 5-Day, and 7-Day MAT Programs

10-Day, 14-Day, 21-Day MAT Programs

Statistics on Medication-Assisted Treatment 

  • 2.6 million individuals in the U.S.  received treatment for alcohol abuse in 2021 and approximately 15% of them utilized MAT as a component of their care
  • An estimated 887,000 individuals in the U.S. utilized MAT for an opioid use disorder in 2021
  • 1 in 5 adults in the U.S. living with an opioid use disorder in 2021 utilized MAT
  • Approximately 75% of overdoses in 2021 involved an opioid, including fentanyl
  • Methadone treatment typically costs 6,552 per year
  • Buprenorphine treatment costs an average of $5,980 per year
  • Naltrexone treatment typically costs around $14,112 per year
  • Approximately 37% of the 20.3 adults  living with a substance use disorder have a mental health illness 

Sources

  1. “Comorbidity: Substance Use and Other Mental Disorders.” National Institutes of Health, May 30, 2023. https://nida.nih.gov/research-topics/comorbidity/comorbidity-substance-use-other-mental-disorders-infographic
  2. Dickson-Gomez, Julia et al. “Insurance barriers to substance use disorder treatment after passage of mental health and addiction parity laws and the Affordable Care Act: A qualitative analysis.” Drug and alcohol dependence reports vol. 3 100051. 31 Mar. 2022, doi:10.1016/j.dadr.2022.100051 
  3. “How Much Does Opioid Treatment Cost?” National Institute on Drug Abuse, April 13, 2021. https://nida.nih.gov/publications/research-reports/medications-to-treat-opioid-addiction/how-much-does-opioid-treatment-cost
  4. “Key Substance Use and Mental Health Indicators in the United States: Results from the 2021 National Survey on Drug Use And …” Substance Abuse and Mental Health Services Administration. Accessed February 17, 2024. https://www.samhsa.gov/data/sites/default/files/reports/rpt39443/2021NSDUHFFRRev010323.pdf
  5. Kumar R, Viswanath O, Saadabadi A. Buprenorphine. [Updated 2023 Nov 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459126/
  6. “Mental Health and Substance Abuse Health Coverage Options.” HealthCare.gov. Accessed February 17, 2024. https://www.healthcare.gov/coverage/mental-health-substance-abuse-coverage/
  7. “Methadone.” Substance Abuse and Mental Health Services Administration. Accessed February 16, 2024. https://www.samhsa.gov/medications-substance-use-disorders/medications-counseling-related-conditions/methadone
  8. “Naltrexone.” Substance Abuse and Mental Health Services Administration. Accessed February 16, 2024. https://www.samhsa.gov/medications-substance-use-disorders/medications-counseling-related-conditions/naltrexone
  9. Sharbaf Shoar N, Bistas KG, Saadabadi A. Flumazenil. [Updated 2023 May 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470180/
  10. “Only 1 in 5 U.S. Adults with Opioid Use Disorder Received Medications to Treat It in 2021.” National Institute on Drug Abuse , October 2, 2023. https://nida.nih.gov/news-events/news-releases/2023/08/only-1-in-5-us-adults-with-opioid-use-disorder-received-medications-to-treat-it-in-2021
  11. Witkiewitz, Katie et al. “Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility.” Therapeutics and clinical risk management vol. 8 (2012): 45-53. doi:10.2147/TCRM.S23184 


Get in touch with Harmony Health Group to find out about our rehab admissions process, free assessment, treatment options or to check your insurance coverage levels. Your first step to recovery starts here!

Provide Your Contact Details

Disclaimer(Required)
Harmony white logo 1 1

8520 Cliff Cameron Dr. Ste 450, Charlotte, NC 28269

Joint Commission Logo